A5048397511- Hepatitis B Virus Studies
- Hepatitis C virus research
- Liver Disease Diagnosis and Treatment
- Healthcare Systems and Reforms
- HIV/AIDS Impact and Responses
- Viral Infections and Outbreaks Research
- Hepatitis Viruses Studies and Epidemiology
Global Fund to Fight AIDS, Tuberculosis and Malaria
2023-2024
Peter Doherty Institute
2017-2022
Institute of Infection and Immunity
2019
The University of Melbourne
2018
Victorian Infectious Diseases Reference Laboratory
2017
We aim to capture the economic impact of a potential cure for chronic hepatitis B infection (CHB) in three countries (USA, China and Australia) with different health systems epidemics estimate threshold drug prices below which CHB would be cost-saving and/or highly cost-effective.We simulated patients' progression, under scenarios: current long-term suppressive antiviral therapy, functional defined as sustained undetectable HBsAg HBV DNA, partial DNA only after finite, 48-week...
Background: Over 257 million people worldwide are chronically infected with hepatitis B virus (HBV), resulting in over 880,000 deaths per year from cirrhosis and liver cancer. There is no known cure for chronic HBV, due part to the continued presence of transcriptionally active DNA nucleus which not directly targeted by current antiviral therapies. Our aim inspire support discovery a safe, scalable effective benefit all living CHB. Methods: To achieve this, we have created an international...